Company / Working Capital
BioAge Labs, Inc. Working Capital History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$266.7M
FY2025
5-year range
-$32.9M / $329.3M
FY2023-FY2025
Trend
-19.0%
vs FY2024
Sector context
#153 of 213
Health Care
What the data says
At $267M, BioAge Labs, Inc.'s working capital ranks #153 of 213 in the Health Care sector. Improved from -$33M to $267M over the past 2 years.
Based on SEC 10-K filings.
$267M in FY2025.
Improved from -$33M to $267M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#153 of 213 in Health CareTop 72% of 213This company $266.7M Sector average $934.6M
▼
-71.5% below sector average
Key checks
Key Insights
- In FY2025, working capital decreased 19.0% year-over-year.
- Ranks #153 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.75 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $266.7M | -19.0% |
| FY2024 | $329.3M | +1102.2% |
| FY2023 | -$32.9M | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026